Skip to Main Content

Healthcare & Life Sciences

The healthcare and life sciences industries face a continually evolving business and regulatory landscape, which can result in a wide range of disputes. Successfully navigating these challenges requires in-depth knowledge of the economic issues in this field combined with a deep understanding of the industry.

The Brattle Group’s experts and consultants combine economic principles, proficiency with institutional features, and extensive data analytics capabilities to assist our clients with issues that arise in disputes, investigations, and regulatory proceedings. We provide economic expertise and expert testimony on matters related to pharmaceuticals, biologics, medical devices, providers, and health insurers.

We are known for developing accessible and persuasive analyses grounded in economic and financial principles, as well as for our close working relationships with leading academics and industry practitioners. We have particular expertise in leveraging data analytics tools to obtain insights from massive healthcare datasets, which can include billions of observations.

Areas of Expertise


Below is a list of representative engagements for our Healthcare & Life Sciences practice.

Assessment of damages arising from healthcare data breach

A Brattle team worked on behalf of the plaintiffs in a class action lawsuit related to a high-profile breach of Premera Blue Cross’s healthcare data. We conducted numerous analyses and prepared reports explaining how to quantify the damage inflicted on the individuals whose personal data was misappropriated. Using a novel approach, we demonstrated how to use data related to dark web sales of personal information to objectively measure consumer losses from the breach.

Pharmaceutical transaction analysis

For a potential multi-billion dollar joint venture between two pharmaceutical manufacturers, a Brattle expert led a global team conducting economic and econometric analyses regarding the possible venture. The analysis supported the proposed transaction, finding relatively little competition between the merging parties’ products. The deal received clearance in multiple jurisdictions, including without second requests in the US.

Successful defense of a monopolization summary judgment on behalf of a major healthcare system

A Brattle expert led a team of economists to support the lead economic expert in a healthcare company’s appeal of monopolization claims leveled against it by a competitor. The lead expert used the results of a series of analyses to demonstrate that the healthcare company’s negotiations with commercial insurers over prices and provider network designs were competitive, and that the complaining competitor had not been hampered in its ability to compete. The appeals court agreed, and affirmed a prior judgement in the client’s favor. 

News & Knowledge